# A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone

> **NCT01010776** · PHASE4 · COMPLETED · sponsor: **Janssen-Cilag Farmaceutica Ltda.** · enrollment: 223 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Paliperidone Extended Release (ER)

## Key facts

- **NCT ID:** NCT01010776
- **Lead sponsor:** Janssen-Cilag Farmaceutica Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2013-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01010776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01010776, "A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01010776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*